Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.
Okamoto N, Yagi K, Imawaka S, Takaoka M, Aizawa F, Niimura T, Goda M, Miyata K, Kawada K, Izawa-Ishizawa Y, Sakaguchi S, Ishizawa K. Okamoto N, et al. Among authors: goda m. Pharmacol Res Perspect. 2024 Aug;12(4):e1214. doi: 10.1002/prp2.1214. Pharmacol Res Perspect. 2024. PMID: 39031848 Free PMC article.
Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study.
Okada N, Kawazoe H, Takechi K, Matsudate Y, Utsunomiya R, Zamami Y, Goda M, Imanishi M, Chuma M, Hidaka N, Sayama K, Kubo Y, Tanaka A, Ishizawa K. Okada N, et al. Among authors: goda m. Clin Ther. 2019 Jan;41(1):59-67. doi: 10.1016/j.clinthera.2018.11.004. Epub 2018 Dec 7. Clin Ther. 2019. PMID: 30528047
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study.
Sakurada T, Bando S, Zamami Y, Takechi K, Chuma M, Goda M, Kirino Y, Nakamura T, Teraoka K, Morimoto M, Tangoku A, Ishizawa K. Sakurada T, et al. Among authors: goda m. Cancer Chemother Pharmacol. 2019 Nov;84(5):1107-1114. doi: 10.1007/s00280-019-03948-6. Epub 2019 Sep 9. Cancer Chemother Pharmacol. 2019. PMID: 31502114
Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway.
Hamano H, Niimura T, Horinouchi Y, Zamami Y, Takechi K, Goda M, Imanishi M, Chuma M, Izawa-Ishizawa Y, Miyamoto L, Fukushima K, Fujino H, Tsuchiya K, Ishizawa K, Tamaki T, Ikeda Y. Hamano H, et al. Among authors: goda m. Toxicol Lett. 2020 Jan;318:86-91. doi: 10.1016/j.toxlet.2019.10.016. Epub 2019 Oct 24. Toxicol Lett. 2020. PMID: 31669099
Search for Therapeutic Agents for Cardiac Arrest Using a Drug Discovery Tool and Large-Scale Medical Information Database.
Zamami Y, Niimura T, Koyama T, Shigemi Y, Izawa-Ishizawa Y, Morita M, Ohshima A, Harada K, Imai T, Hagiwara H, Okada N, Goda M, Takechi K, Chuma M, Kondo Y, Tsuchiya K, Hinotsu S, Kano MR, Ishizawa K. Zamami Y, et al. Among authors: goda m. Front Pharmacol. 2019 Nov 8;10:1257. doi: 10.3389/fphar.2019.01257. eCollection 2019. Front Pharmacol. 2019. PMID: 31780928 Free PMC article.
Rho-associated protein kinase and cyclophilin a are involved in inorganic phosphate-induced calcification signaling in vascular smooth muscle cells.
Tsuda T, Imanishi M, Oogoshi M, Goda M, Kihira Y, Horinouchi Y, Zamami Y, Ishizawa K, Ikeda Y, Hashimoto I, Tamaki T, Izawa-Ishizawa Y. Tsuda T, et al. Among authors: goda m. J Pharmacol Sci. 2020 Mar;142(3):109-115. doi: 10.1016/j.jphs.2019.12.005. Epub 2019 Dec 16. J Pharmacol Sci. 2020. PMID: 31882204 Free article.
275 results